The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?

Multiple sclerosis is (MS) a T‐cell autoimmune disease characterized by a relapsing‐remitting followed by a progressive phase. Relapses are driven by the adaptive immune system and involve waves of T helper cell 1 (Th1), Th17, and CD8 cells that infiltrate the nervous system and provoke a attack. Th...

Ausführliche Beschreibung